Mainstay Medical passes ‘important milestone’ in clinical trials
Firm aims to bring its new therapy for chronic lower back pain to key US market
Firm aims to bring its new therapy for chronic lower back pain to key US market
Irish company positive about clinical trial stemming from its ReActiv8-B product
Company has already begun commercialising back pain device in Europe
Iseq-listed medical device firm targets commercial growth and completion of US clinical trials
Dublin-listed firm pushes ahead with plans to commercialise back pain treatment
Company’s flagship product ReActiv8 won European approval earlier this year
Operating expenses also decline while R&D and clinical and regulatory costs rise
Irish company has won European approval of neurostimulator to treat chronic lower back pain and targeting US market
A trial of 47 patients showed after three months, 63 per cent reported clinically important improvement in back pain
Dublin-listed company pushing forward with plans to bring Reactiv8 to market
Irish medical devices company pushes ahead with clinical trials for ReActiv8
Proceeds will fund clinical trials of back pain device as shares float at lower end of guided range
Three years to get a product to trials
Implanted Reactiv8 unit designed to stabilise spinal muscles with electrical impulses
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices